Show simple item record

Files in this item

Cover for Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer
dc.contributor.advisorWellstein, Antonen
dc.creatoren
dc.date.accessioned2014-08-21T19:27:01Zen
dc.date.created2014en
dc.date.issueden
dc.date.submitted01/01/2014en
dc.identifier.otherAPT-BAG: georgetown.edu.10822_710048.tar;APT-ETAG: 7b4ead23f442d13332c2e40329ab3bee; APT-DATE: 2017-01-30_12:13:16en
dc.identifier.urien
dc.descriptionPh.D.en
dc.description.abstractAn early detection and monitoring of pancreatic adenocarcinoma has been very challenging, which makes it one of the deadliest cancers today. This has stimulated research to explore new therapeutic strategies and new ways of following treatment response. We believe that miRNAs play an important role in cancer, and circulating miRNAs from peripheral blood could not only be used as early diagnostic biomarkers, but their expression profile could give us a valuable clue about response to therapy.en
dc.description.abstractWe focus on targeting tumor-stroma interaction in a pancreatic cancer xenograft mouse model, with two small molecule inhibitors: (1) a fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, PD173074; and (2) an anaplastic lymphoma kinase receptor (ALK) kinase inhibitor, TAE684. Both drugs reduced COLO357PL pancreatic cancer cell proliferation and disruption of endothelial cell monolayer by cancer cells in vitro. In vivo, initial treatment with both drugs reduced mitosis and angiogenesis similarly. First, we identified serum miRNA expression changes as a response to the tumor presence. Furthermore, we describe a distinctive set of circulating miRNAs that corresponds to each initial treatment before necrotic changes took place and influenced miRNA expression pattern. More importantly, in our study we distinguish between drug effect on the tumor versus host, based on the miRNA expression changes in tumor tissue and the circulation. Finally, we show a connection between successful treatment of pancreatic cancer xenografts and the circulating miRNA expression pattern.en
dc.description.abstractThe approach of determining circulating miRNA expression levels and patterns upon the initial treatment could be of immense importance for pancreatic cancer patients in finding the effective drug (combination) treatment and might be a model to expand to other cancers and treatment evaluations.en
dc.formatPDFen
dc.format.extent134 leavesen
dc.languageenen
dc.publisherGeorgetown Universityen
dc.sourceGeorgetown University-Graduate School of Arts & Sciencesen
dc.sourceTumor Biologyen
dc.subjectALKen
dc.subjectFGFRen
dc.subjectmiRNAen
dc.subjectpancreatic canceren
dc.subjecttreatment responseen
dc.subject.lcshOncologyen
dc.subject.lcshCytologyen
dc.subject.lcshMolecular biologyen
dc.subject.otherOncologyen
dc.subject.otherCellular biologyen
dc.subject.otherMolecular biologyen
dc.titleDistinct Response of Circulating microRNAs to the Treatment of Pancreatic Canceren
dc.typethesisen
gu.embargo.lift-date2015-08-21en
gu.embargo.terms1-yearen


This item appears in the following Collection(s)

Show simple item record